Biogen (BIIB) News Today $141.95 -1.65 (-1.15%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIIB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $19.79 Million Stake in Biogen Inc. $BIIBSeptember 10 at 5:16 AM | marketbeat.comJacobs Levy Equity Management Inc. Makes New Investment in Biogen Inc. $BIIBSeptember 10 at 5:04 AM | marketbeat.comAlliancebernstein L.P. Has $31.34 Million Stock Position in Biogen Inc. $BIIBSeptember 10 at 3:54 AM | marketbeat.comNissay Asset Management Corp Japan ADV Grows Stock Position in Biogen Inc. $BIIBSeptember 9 at 5:14 AM | marketbeat.comGotham Asset Management LLC Grows Holdings in Biogen Inc. $BIIBSeptember 9 at 4:54 AM | marketbeat.comAdage Capital Partners GP L.L.C. Takes $9.68 Million Position in Biogen Inc. $BIIBSeptember 9 at 4:15 AM | marketbeat.comBiogen Inc. (BIIB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8 at 7:30 PM | seekingalpha.comRoyal Bank of Canada Raises Stock Holdings in Biogen Inc. $BIIBSeptember 8 at 4:36 AM | marketbeat.comBiogen (NASDAQ:BIIB) Rating Increased to Strong-Buy at Wall Street ZenSeptember 8 at 2:49 AM | americanbankingnews.comBrokerages Set Biogen Inc. (NASDAQ:BIIB) Target Price at $185.74September 8 at 2:09 AM | americanbankingnews.comCinctive Capital Management LP Buys Shares of 7,894 Biogen Inc. $BIIBSeptember 7 at 6:05 AM | marketbeat.comAmundi Grows Holdings in Biogen Inc. $BIIBSeptember 7 at 5:21 AM | marketbeat.comFocus Partners Advisor Solutions LLC Makes New $725,000 Investment in Biogen Inc. $BIIBSeptember 7 at 4:57 AM | marketbeat.comVident Advisory LLC Grows Stake in Biogen Inc. $BIIBSeptember 7 at 4:21 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 7 at 3:27 AM | marketbeat.comBiogen (NASDAQ:BIIB) Receives "Hold" Rating from Needham & Company LLCSeptember 7 at 2:25 AM | americanbankingnews.comWhy Biogen (BIIB) Is Up 6.4% After At-Home Alzheimer’s Therapy and Dravet Data UpdatesSeptember 6, 2025 | finance.yahoo.comBiogen's (BIIB) Hold Rating Reaffirmed at Needham & Company LLCSeptember 6, 2025 | marketbeat.comCutter Capital Management LP Makes New $15.53 Million Investment in Biogen Inc. $BIIBSeptember 6, 2025 | marketbeat.comBanque Transatlantique SA Makes New $428,000 Investment in Biogen Inc. $BIIBSeptember 6, 2025 | marketbeat.comBiogen Inc. $BIIB Shares Purchased by AQR Capital Management LLCSeptember 6, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Sells 4,410 Shares of Biogen Inc. $BIIBSeptember 6, 2025 | marketbeat.comRaymond James Financial Inc. Trims Stock Holdings in Biogen Inc. $BIIBSeptember 6, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Insider Priya Singhal Sells 517 SharesSeptember 4, 2025 | marketbeat.comSpinal Muscular Atrophy Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Novartis, Hoffmann-La Roche, Genentech, Inc., Scholar Rock, Roche ...September 4, 2025 | theglobeandmail.com5BIIB : Beyond The Numbers: 10 Analysts Discuss Biogen StockSeptember 4, 2025 | benzinga.comBiogen (BIIB) Stock Trades Down, Here Is WhySeptember 4, 2025 | msn.comBiogen (NASDAQ:BIIB) Shares Up 5.1% - Here's What HappenedSeptember 4, 2025 | marketbeat.comBiogen’s Strategic Focus on Lupus Innovations and Pipeline Diversification Earns Buy RatingSeptember 4, 2025 | tipranks.comBiogen’s Strategic Positioning and Potential Leadership in the Lupus Treatment MarketSeptember 4, 2025 | tipranks.comBiogen Inc. $BIIB Position Raised by Palo Alto Investors LPSeptember 4, 2025 | marketbeat.comBiogen’s Stable Near-Term Outlook with Promising Long-Term Growth in Immunology PipelineSeptember 4, 2025 | tipranks.com3,042 Shares in Biogen Inc. $BIIB Acquired by Evergreen Capital Management LLCSeptember 4, 2025 | marketbeat.comBiogen’s Competitive Edge: FDA Approval of Leqembi IQLIK Boosts Buy RatingSeptember 4, 2025 | tipranks.comGlobal drugmakers rush to boost US presence as tariff threat loomsSeptember 3, 2025 | reuters.comEisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of ...September 3, 2025 | finance.yahoo.comBiogen, Eisai begin rolling FDA submissions for Leqembi injectable for starting doseSeptember 3, 2025 | msn.comEisai, Biogen initiate rolling BLA to FDA for LEQEMBISeptember 3, 2025 | msn.comBiogen (BIIB) Stock Is Up, What You Need To KnowSeptember 3, 2025 | finance.yahoo.comBiogen Inc. $BIIB Stock Position Decreased by Canada Pension Plan Investment BoardSeptember 3, 2025 | marketbeat.comBiogen Inc. $BIIB Holdings Raised by Trexquant Investment LPSeptember 3, 2025 | marketbeat.comLandscape Capital Management L.L.C. Takes $329,000 Position in Biogen Inc. $BIIBSeptember 3, 2025 | marketbeat.comBNP Paribas Financial Markets Has $50.11 Million Stock Holdings in Biogen Inc. $BIIBSeptember 3, 2025 | marketbeat.comEisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track StatusSeptember 2, 2025 | globenewswire.comBiogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine ...September 2, 2025 | markets.businessinsider.com82,476 Shares in Biogen Inc. $BIIB Bought by Point72 Europe London LLPSeptember 2, 2025 | marketbeat.comBiogen and Stoke Therapeutics Announce Three-Year Results Supporting Zorevunersen's Promise for Dravet Syndrome TreatmentSeptember 2, 2025 | quiverquant.comQBiogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet SyndromeSeptember 2, 2025 | financialpost.comFBiogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet SyndromeSeptember 2, 2025 | globenewswire.comCautious Outlook for Biogen Amid New Developments and Competitive PressuresSeptember 2, 2025 | tipranks.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼1.070.84▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3527▲BIIB Articles Average Week Get the Latest News and Ratings for BIIB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Biogen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amgen News Today Denali Therapeutics News Today Gilead Sciences News Today Ionis Pharmaceuticals News Today Moderna News Today Prothena News Today Cassava Sciences News Today Vertex Pharmaceuticals News Today Bristol Myers Squibb News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
